These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35191551)

  • 41. Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.
    Bekis Bozkurt H; Bayram Catak F; Sahin A; Yalcin Gungoren E; Gemici Karaarslan B; Yakici N; Yorgun Altunbas M; Catak MC; Can S; Amirov R; Bozkurt S; Ozturk N; Bilgic Eltan S; Kasap N; Bal Cetinkaya F; Orhan F; Arga M; Cavkaytar O; Kiykim A; Karakoc-Aydiner E; Ozen A; Baris S
    J Clin Immunol; 2024 Sep; 45(1):9. PubMed ID: 39283523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.
    Baxter SK; Walsh T; Casadei S; Eckert MM; Allenspach EJ; Hagin D; Segundo G; Lee MK; Gulsuner S; Shirts BH; Sullivan KE; Keller MD; Torgerson TR; King MC
    J Allergy Clin Immunol; 2022 Jan; 149(1):327-339. PubMed ID: 33864888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXP3 deficiency, from the mechanisms of the disease to curative strategies.
    Borna S; Meffre E; Bacchetta R
    Immunol Rev; 2024 Mar; 322(1):244-258. PubMed ID: 37994657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A hemizygous mutation in the FOXP3 gene (IPEX syndrome) resulting in recurrent X-linked fetal hydrops: a case report.
    Shangaris P; Ho A; Marnerides A; George S; AlAdnani M; Yau S; Jansson M; Hoyle J; Ahn JW; Ellard S; Irving M; Wellesley D; Pasupathy D; Holder-Espinasse M
    BMC Med Genomics; 2021 Feb; 14(1):58. PubMed ID: 33637067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea.
    Zama D; Cocchi I; Masetti R; Specchia F; Alvisi P; Gambineri E; Lima M; Pession A
    Ital J Pediatr; 2014 Oct; 40():68. PubMed ID: 25326164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.
    Ochs HD; Gambineri E; Torgerson TR
    Immunol Res; 2007; 38(1-3):112-21. PubMed ID: 17917016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome.
    Jamee M; Zaki-Dizaji M; Lo B; Abolhassani H; Aghamahdi F; Mosavian M; Nademi Z; Mohammadi H; Jadidi-Niaragh F; Rojas M; Anaya JM; Azizi G
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2747-2760.e7. PubMed ID: 32428713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New Findings of Immunodysregulation, Polyendocrinopathy, and Enteropathy X-linked Syndrome (IPEX); Granulomas in Lung and Duodenum.
    Duztas DT; Al-Shadfan L; Ozturk H; Yazan H; Cakir E; Ekinci NUO; Dalgic B; Rohlfs M; Jeske T; Klein C; Kotlarz D; Gurkan OE
    Pediatr Dev Pathol; 2021; 24(3):252-257. PubMed ID: 33683986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.
    Torgerson TR; Linane A; Moes N; Anover S; Mateo V; Rieux-Laucat F; Hermine O; Vijay S; Gambineri E; Cerf-Bensussan N; Fischer A; Ochs HD; Goulet O; Ruemmele FM
    Gastroenterology; 2007 May; 132(5):1705-17. PubMed ID: 17484868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.
    Smith E; Greeley SA; Ye H; Torgerson TR; Dimmitt R; Atkinson P; Philips J; Goldman F
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e119-e120. PubMed ID: 25187107
    [No Abstract]   [Full Text] [Related]  

  • 51. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome.
    Yamauchi T; Takasawa K; Kamiya T; Kirino S; Gau M; Inoue K; Hoshino A; Kashimada K; Kanegane H; Morio T
    Pediatr Diabetes; 2019 Nov; 20(7):1035-1040. PubMed ID: 31322807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.
    Charbonnier LM; Janssen E; Chou J; Ohsumi TK; Keles S; Hsu JT; Massaad MJ; Garcia-Lloret M; Hanna-Wakim R; Dbaibo G; Alangari AA; Alsultan A; Al-Zahrani D; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2015 Jan; 135(1):217-27. PubMed ID: 25468195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a novel nonsense mutation in the FOXP3 gene in a fetus with hydrops--Expanding the phenotype of IPEX syndrome.
    Reichert SL; McKay EM; Moldenhauer JS
    Am J Med Genet A; 2016 Jan; 170A(1):226-32. PubMed ID: 26395338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Girl with IPEX syndrome with low expression of Foxp3].
    Horiuchi S; Ishiguro A; Nakagawa T; Shoji K; Nagai A; Arai K; Horikawa R; Kawai T; Watanabe N; Onodera M
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):526-32. PubMed ID: 23291488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Halabi-Tawil M; Ruemmele FM; Fraitag S; Rieux-Laucat F; Neven B; Brousse N; De Prost Y; Fischer A; Goulet O; Bodemer C
    Br J Dermatol; 2009 Mar; 160(3):645-51. PubMed ID: 18795917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.
    Chen CA; Chung WC; Chiou YY; Yang YJ; Lin YC; Ochs HD; Shieh CC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):775-782. PubMed ID: 26748735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Martín-Santiago A; Hervás JA; Hervás D; Rosell A; Caimari M; de Carlos JC; Matamoros N
    Pediatr Dermatol; 2013; 30(6):e221-2. PubMed ID: 23534934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
    Park JH; Lee KH; Jeon B; Ochs HD; Lee JS; Gee HY; Seo S; Geum D; Piccirillo CA; Eisenhut M; van der Vliet HJ; Lee JM; Kronbichler A; Ko Y; Shin JI
    Autoimmun Rev; 2020 Jun; 19(6):102526. PubMed ID: 32234571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in two cases].
    Zhu Q; Yuan K; Wang C; Fang Y; Zhu J; Liang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):389-392. PubMed ID: 29896738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
    Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.